These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23861803)

  • 1. Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease.
    Gonzalo-Gobernado R; Calatrava-Ferreras L; Reimers D; Herranz AS; Rodríguez-Serrano M; Miranda C; Jiménez-Escrig A; Díaz-Gil JJ; Bazán E
    PLoS One; 2013; 8(7):e67771. PubMed ID: 23861803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats.
    Reimers D; Herranz AS; Díaz-Gil JJ; Lobo MV; Paíno CL; Alonso R; Asensio MJ; Gonzalo-Gobernado R; Bazán E
    J Histochem Cytochem; 2006 Apr; 54(4):457-65. PubMed ID: 16344326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of neural stem cells and generation of new neurons in 6-OHDA-lesioned rats by intracerebroventricular infusion of liver growth factor.
    Gonzalo-Gobernado R; Reimers D; Herranz AS; Díaz-Gil JJ; Osuna C; Asensio MJ; Baena S; Rodríguez-Serrano M; Bazán E
    J Histochem Cytochem; 2009 May; 57(5):491-502. PubMed ID: 19188487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway.
    Xu L; Chen WF; Wong MS
    Br J Pharmacol; 2009 Oct; 158(3):738-48. PubMed ID: 19703168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.
    Carbone M; Duty S; Rattray M
    BMC Neurosci; 2012 Apr; 13():38. PubMed ID: 22480308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.
    Park HJ; Lim S; Joo WS; Yin CS; Lee HS; Lee HJ; Seo JC; Leem K; Son YS; Kim YJ; Kim CJ; Kim YS; Chung JH
    Exp Neurol; 2003 Mar; 180(1):93-8. PubMed ID: 12668152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver growth factor as a tissue regenerating factor in neurodegenerative diseases.
    Gonzalo-Gobernado R; Calatrava-Ferreras L; Perucho J; Reimers D; Casarejos MJ; Herranz AS; Jimenez-Escrig A; Diaz-Gil JJ; Bazan E
    Recent Pat CNS Drug Discov; 2014; 9(3):173-80. PubMed ID: 25537484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
    Zhang L; Huang L; Chen L; Hao D; Chen J
    Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's disease.
    Reimers D; Osuna C; Gonzalo-Gobernado R; Herranz AS; Diaz-Gil JJ; Jimenez-Escrig A; Asensio MJ; Miranda C; Rodriguez-Serrano M; Bazan E
    Curr Stem Cell Res Ther; 2012 Jan; 7(1):15-25. PubMed ID: 21190529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective role of liver growth factor "LGF" in an experimental model of cerebellar ataxia.
    Calatrava-Ferreras L; Gonzalo-Gobernado R; Reimers D; Herranz AS; Jiménez-Escrig A; Díaz-Gil JJ; Casarejos MJ; Montero-Vega MT; Bazán E
    Int J Mol Sci; 2014 Oct; 15(10):19056-73. PubMed ID: 25338046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Sleeman IJ; Boshoff EL; Duty S
    Neuropharmacology; 2012 Dec; 63(7):1268-77. PubMed ID: 22971544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.